Rucaparib: A Powerful PARP Inhibitor for Cancer Patients

added blog Health

2025-02-11 09:20:02 -

Rucaparib is a potent PARP (Poly ADP-Ribose Polymerase) inhibitor that has revolutionized cancer treatment, particularly for patients with advanced ovarian, prostate, and other BRCA-mutated cancers. By inhibiting the PARP enzyme, Rucaparib prevents cancer cells from repairing their damaged DNA, leading to cell death and tumor reduction. This targeted mechanism enhances its effectiveness while...

0 Comments 0 Shares 167 Views 0 Reviews